Literature DB >> 17497551

Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL).

Chris Derauf1, Linda L LaGasse, Lynne M Smith, Penny Grant, Rizwan Shah, Amelia Arria, Marilyn Huestis, William Haning, Arthur Strauss, Sheri Della Grotta, Jing Liu, Barry M Lester.   

Abstract

This study describes the psychological characteristics and caretaking environments of 131 women enrolled in the first longitudinal study of prenatal methamphetamine (MA) exposure and child development. Prenatal MA use was associated with lower maternal perceptions on quality of life, greater likelihood of substance use among family and friends, increased risk for ongoing legal difficulties, and a markedly increased likelihood of developing a substance abuse disorder. Our preliminary findings suggest that MA using women are more likely to have multiple, intertwined psychosocial risks that may result in maladaptive parenting and caregiving. These factors may impact the developmental outcomes of affected children.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497551      PMCID: PMC2737408          DOI: 10.1080/00952990601175029

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  12 in total

Review 1.  Functional aspects of estrogen neuroprotection.

Authors:  Veronica Bisagno; Rachel Bowman; Victoria Luine
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

2.  Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study.

Authors:  Amelia M Arria; Chris Derauf; Linda L Lagasse; Penny Grant; Rizwan Shah; Lynne Smith; William Haning; Marilyn Huestis; Arthur Strauss; Sheri Della Grotta; Jing Liu; Barry Lester
Journal:  Matern Child Health J       Date:  2006-01-05

3.  History of the methamphetamine problem.

Authors:  M D Anglin; C Burke; B Perrochet; E Stamper; S Dawud-Noursi
Journal:  J Psychoactive Drugs       Date:  2000 Apr-Jun

Review 4.  Demographic and psychosocial characteristics of substance-abusing pregnant women.

Authors:  S L Hans
Journal:  Clin Perinatol       Date:  1999-03       Impact factor: 3.430

5.  Prevalence and magnitude of perinatal substance exposures in California.

Authors:  W A Vega; B Kolody; J Hwang; A Noble
Journal:  N Engl J Med       Date:  1993-09-16       Impact factor: 91.245

6.  Risk factors for disruption in primary caregiving among infants of substance abusing women.

Authors:  P Nair; M M Black; M Schuler; V Keane; L Snow; B A Rigney; L Magder
Journal:  Child Abuse Negl       Date:  1997-11

7.  Children prenatally exposed to cocaine: developmental outcomes and environmental risks at seven years of age.

Authors:  Robert E Arendt; Elizabeth J Short; Lynn T Singer; Sonia Minnes; Julie Hewitt; Sarah Flynn; Lisa Carlson; Meeyoung O Min; Nancy Klein; Daniel Flannery
Journal:  J Dev Behav Pediatr       Date:  2004-04       Impact factor: 2.225

8.  Children of mothers with serious substance abuse problems: an accumulation of risks.

Authors:  Nicola A Conners; Robert H Bradley; Leanne Whiteside Mansell; Jeffrey Y Liu; Tracy J Roberts; Ken Burgdorf; James M Herrell
Journal:  Am J Drug Alcohol Abuse       Date:  2004       Impact factor: 3.829

9.  Cumulative environmental risk in substance abusing women: early intervention, parenting stress, child abuse potential and child development.

Authors:  Prasanna Nair; Maureen E Schuler; Maureen M Black; Laurie Kettinger; Donna Harrington
Journal:  Child Abuse Negl       Date:  2003-09

10.  Psychiatric symptoms in methamphetamine users.

Authors:  Joan E Zweben; Judith B Cohen; Darrell Christian; Gantt P Galloway; Michelle Salinardi; David Parent; Martin Iguchi
Journal:  Am J Addict       Date:  2004 Mar-Apr
View more
  22 in total

1.  Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years.

Authors:  Trecia A Wouldes; Linda L Lagasse; Marilyn A Huestis; Sheri Dellagrotta; Lynne M Dansereau; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2014-02-22       Impact factor: 3.763

2.  Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age.

Authors:  Sabrina D Diaz; Lynne M Smith; Linda L LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Amelia Arria; Marilyn A Huestis; Sheri Della Grotta; Lynne M Dansereau; Charles Neal; Barry M Lester
Journal:  J Pediatr       Date:  2014-03-12       Impact factor: 4.406

Review 3.  Illicit substance use in pregnancy - a review.

Authors:  Katherine Scott; Karin Lust
Journal:  Obstet Med       Date:  2010-09-17

4.  Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes.

Authors:  Rizwan Shah; Sabrina D Diaz; Amelia Arria; Linda L LaGasse; Chris Derauf; Elana Newman; Lynne M Smith; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Lynne M Dansereau; Mary B Roberts; Charles Neal; Barry M Lester
Journal:  Am J Perinatol       Date:  2012-03-07       Impact factor: 1.862

Review 5.  Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women.

Authors:  Marcela C Smid; Torri D Metz; Adam J Gordon
Journal:  Clin Obstet Gynecol       Date:  2019-03       Impact factor: 2.190

6.  Cortisol reactivity in two-year-old children prenatally exposed to methamphetamine.

Authors:  Namik Kirlic; Elana Newman; Linda L Lagasse; Chris Derauf; Rizwan Shah; Lynne M Smith; Amelia M Arria; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Dellagrotta; Lynne M Dansereau; Beau Abar; Charles R Neal; Barry M Lester
Journal:  J Stud Alcohol Drugs       Date:  2013-05       Impact factor: 2.582

Review 7.  Prenatal exposure to drugs: effects on brain development and implications for policy and education.

Authors:  Barbara L Thompson; Pat Levitt; Gregg D Stanwood
Journal:  Nat Rev Neurosci       Date:  2009-03-11       Impact factor: 34.870

8.  Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioral problems at 5 years.

Authors:  Jean Twomey; Linda LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Lynne Smith; Amelia Arria; Marilyn Huestis; Sheri DellaGrotta; Mary Roberts; Lynne Dansereau; Charles Neal; Barry Lester
Journal:  Am J Orthopsychiatry       Date:  2013-01

Review 9.  Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) study.

Authors:  Lynne M Smith; Sabrina Diaz; Linda L LaGasse; Trecia Wouldes; Chris Derauf; Elana Newman; Amelia Arria; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Lynne M Dansereau; Charles Neal; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2015-07-23       Impact factor: 3.763

Review 10.  Ocular manifestations of crystal methamphetamine use.

Authors:  Ribhi Hazin; Jean Lud Cadet; Malik Y Kahook; Dunia Saed
Journal:  Neurotox Res       Date:  2009-02-28       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.